The selection of monoclonal antibodies for tumour localization in patients with colorectal carcinoma
- PMID: 6544894
- DOI: 10.1007/BF02934976
The selection of monoclonal antibodies for tumour localization in patients with colorectal carcinoma
Abstract
We have investigated the ability of various predictive studies to assess which monoclonal antibody (MCA) will be most useful in the immunoscintigraphic localization of metastatic colorectal carcinoma. A set of MCAs was obtained by fusing splenic lymphocytes from rats immunized with membrane preparations from fresh human colorectal cancer. Supernatants from 17 cloned hybridomas were found to bind strongly to colon carcinoma lines by indirect radioimmunoassay. Immunofluorescence using these MCAs on sections of fresh frozen colon carcinoma and normal tissue revealed different staining patterns. Nine MCAs were purified and labelled with 131I. Groups of mice bearing human colorectal tumour xenografts were given radiolabelled MCA and scanned. Six out of the nine MCAs showed tumour localization as determined by rectilinear scanning. Three MCAs which gave good tumour images in mice were selected for clinical evaluation in patients with advanced colorectal cancer. One gave good tumour images, another targeted to bone marrow and the third bound almost exclusively to normal liver. Clinical evaluation is clearly essential in the selection of MCAs for tumour localization.
Similar articles
-
Monoclonal antibodies from mice bearing human colorectal carcinoma xenografts.Med Oncol Tumor Pharmacother. 1986;3(1):5-9. doi: 10.1007/BF02934569. Med Oncol Tumor Pharmacother. 1986. PMID: 3702511
-
Generation of tumor cell-reactive human monoclonal antibodies using peripheral blood lymphocytes from actively immunized colorectal carcinoma patients.Cancer Res. 1985 Aug;45(8):3951-61. Cancer Res. 1985. PMID: 4016762
-
Preclinical studies on the pharmacokinetic properties of human monoclonal antibodies to colorectal cancer and their use for detection of tumors.Cancer Res. 1988 Aug 1;48(15):4348-53. Cancer Res. 1988. PMID: 3390831
-
Localisation of metastatic carcinoma by a radiolabelled monoclonal antibody.Br J Cancer. 1983 Feb;47(2):253-9. doi: 10.1038/bjc.1983.33. Br J Cancer. 1983. PMID: 6337613 Free PMC article.
-
Antibody markers.Br J Surg. 1985 Sep;72 Suppl:S42. doi: 10.1002/bjs.1800721324. Br J Surg. 1985. PMID: 3899258 Review. No abstract available.
Cited by
-
Tumor scintigraphy with 131I anti CEA monoclonal antibodies and F(ab')2 in colorectal cancer.Eur J Nucl Med. 1987;13(3):125-9. doi: 10.1007/BF00289023. Eur J Nucl Med. 1987. PMID: 3622555 Clinical Trial.